Teleflex’s (TFX) “Sell (D+)” Rating Reiterated at Weiss Ratings

Weiss Ratings restated their sell (d+) rating on shares of Teleflex (NYSE:TFX) in a research report released on Friday morning,Weiss Ratings reports.

Several other brokerages also recently weighed in on TFX. Royal Bank Of Canada upped their target price on shares of Teleflex from $130.00 to $135.00 and gave the stock a “sector perform” rating in a research note on Friday, August 1st. Zacks Research downgraded shares of Teleflex from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 30th. Wall Street Zen downgraded shares of Teleflex from a “strong-buy” rating to a “buy” rating in a research note on Monday, September 15th. Wells Fargo & Company cut their target price on shares of Teleflex from $137.00 to $131.00 and set an “equal weight” rating on the stock in a research note on Friday, August 1st. Finally, Mizuho upped their target price on shares of Teleflex from $130.00 to $135.00 and gave the stock a “neutral” rating in a research note on Friday, August 1st. One investment analyst has rated the stock with a Buy rating, nine have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Reduce” and a consensus price target of $141.57.

Teleflex Stock Performance

Shares of TFX stock opened at $132.12 on Friday. The firm’s 50 day moving average price is $126.28 and its 200-day moving average price is $123.58. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.44 and a current ratio of 2.41. Teleflex has a one year low of $108.90 and a one year high of $239.13. The firm has a market cap of $5.84 billion, a P/E ratio of 31.09, a P/E/G ratio of 1.84 and a beta of 1.05.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.73 EPS for the quarter, topping the consensus estimate of $3.36 by $0.37. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The firm had revenue of $780.90 million for the quarter, compared to analyst estimates of $771.53 million. During the same period in the prior year, the business posted $3.42 EPS. The business’s revenue for the quarter was up 4.2% compared to the same quarter last year. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. As a group, equities research analysts predict that Teleflex will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, September 15th. Shareholders of record on Friday, August 15th were issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.0%. The ex-dividend date was Friday, August 15th. Teleflex’s payout ratio is 32.00%.

Insider Activity at Teleflex

In related news, Director Stuart A. Randle bought 1,000 shares of the stock in a transaction dated Tuesday, August 5th. The stock was acquired at an average price of $115.86 per share, for a total transaction of $115,860.00. Following the acquisition, the director owned 7,547 shares in the company, valued at approximately $874,395.42. This represents a 15.27% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Liam Kelly bought 1,500 shares of the stock in a transaction dated Tuesday, August 5th. The stock was bought at an average price of $115.07 per share, with a total value of $172,605.00. Following the acquisition, the chief executive officer owned 45,267 shares in the company, valued at approximately $5,208,873.69. This represents a 3.43% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired a total of 5,500 shares of company stock worth $633,590 over the last ninety days. 1.40% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Teacher Retirement System of Texas acquired a new position in shares of Teleflex in the 1st quarter valued at $1,242,000. Amalgamated Bank boosted its holdings in shares of Teleflex by 56.9% in the 1st quarter. Amalgamated Bank now owns 14,046 shares of the medical technology company’s stock valued at $1,941,000 after buying an additional 5,095 shares in the last quarter. New York State Teachers Retirement System boosted its holdings in shares of Teleflex by 13.9% in the 1st quarter. New York State Teachers Retirement System now owns 45,063 shares of the medical technology company’s stock valued at $6,227,000 after buying an additional 5,482 shares in the last quarter. NorthCrest Asset Manangement LLC acquired a new position in shares of Teleflex in the 2nd quarter valued at $299,000. Finally, Brown Advisory Inc. boosted its holdings in shares of Teleflex by 34.2% in the 1st quarter. Brown Advisory Inc. now owns 2,524 shares of the medical technology company’s stock valued at $349,000 after buying an additional 643 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.